- Home
- ASPS vs TRAW Comparison
ASPS vs TRAW Comparison
Compare ASPS & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- TRAW
- Stock Information
- Founded
- ASPS 1999
- TRAW 1998
- Country
- ASPS Luxembourg
- TRAW United States
- Employees
- ASPS N/A
- TRAW N/A
- Industry
- ASPS Other Consumer Services
- TRAW
- Sector
- ASPS Consumer Discretionary
- TRAW
- Exchange
- ASPS Nasdaq
- TRAW NYSE
- Market Cap
- ASPS 9.2M
- TRAW 7.8M
- IPO Year
- ASPS N/A
- TRAW 2013
- Fundamental
- Price
- ASPS $8.58
- TRAW $1.40
- Analyst Decision
- ASPS
- TRAW
- Analyst Count
- ASPS 0
- TRAW 0
- Target Price
- ASPS N/A
- TRAW N/A
- AVG Volume (30 Days)
- ASPS 66.7K
- TRAW 3.4M
- Earning Date
- ASPS 07-24-2025
- TRAW 08-14-2025
- Dividend Yield
- ASPS N/A
- TRAW N/A
- EPS Growth
- ASPS N/A
- TRAW N/A
- EPS
- ASPS N/A
- TRAW N/A
- Revenue
- ASPS $164,104,000.00
- TRAW $227,000.00
- Revenue This Year
- ASPS $38.29
- TRAW $3.81
- Revenue Next Year
- ASPS N/A
- TRAW $30.43
- P/E Ratio
- ASPS N/A
- TRAW N/A
- Revenue Growth
- ASPS 13.12
- TRAW 0.44
- 52 Week Low
- ASPS $3.46
- TRAW $0.97
- 52 Week High
- ASPS $13.12
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- ASPS 57.42
- TRAW 42.63
- Support Level
- ASPS $9.80
- TRAW $1.62
- Resistance Level
- ASPS $11.07
- TRAW $1.77
- Average True Range (ATR)
- ASPS 0.99
- TRAW 0.15
- MACD
- ASPS 0.14
- TRAW -0.03
- Stochastic Oscillator
- ASPS 61.38
- TRAW 10.34
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.